Topical compositions comprising dead sea water and uses thereof
AssigneeAhava - Dead Sea Laboratories Ltd.
InventorsIsabelle Rachel AFRIAT-STALOFF, Meital Portugal COHEN, Zeevi MAOR, Dror COHEN
Life of this patent
Estimating the term…
Loading patent…
AssigneeAhava - Dead Sea Laboratories Ltd.
InventorsIsabelle Rachel AFRIAT-STALOFF, Meital Portugal COHEN, Zeevi MAOR, Dror COHEN
Estimating the term…
The present disclosure provides method of inducing secretion of beta-endorphin in a skin region of a subject, the method comprises topically applying a composition comprising at least 0.5% Dead Sea Water onto a skin region of a subject. The disclosure further provides a method of modifying at least one condition of a skin region of a subject, the method comprises topically applying a composition comprising at least 0.5% Dead Sea Water onto the skin region of the subject, wherein the at least one skin condition is selected from the group consisting of mechanical and physiological skin condition and wherein the modifying of the at least one skin condition is associated with induction of skin beta-endorphin secretion in the skin region.
A method of inducing secretion of beta-endorphin in a skin region of a subject, the method comprising topically applying a composition comprising at least 0.5% Dead Sea Water onto said skin region of said subject.
A method of inducing secretion of beta-endorphin in a skin region of a subject, the method comprising topically applying a composition comprising at least 0.5% Dead Sea Water onto said skin region of said subject, wherein the secretion is induced over a period of 48 hours post the topical application of said composition onto said skin region of the subject.
A method of modifying at least one condition of a skin region of a subject, the method comprising topically applying a composition comprising at least 0.5% Dead Sea Water onto the skin region of the subject, wherein the at least one condition is selected from the group consisting of mechanical and physiological skin condition and wherein the modifying of the at least one skin condition is associated with induction of skin beta-endorphin secretion in the skin region.
Dependencies are inferred from the claim text.